These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31855567)

  • 21. COMPARISON OF THAI GOVERNMENT MANUFACTURED TENOFOVIR (TENOFOVIR GPO300) WITH PRIVATELY MANUFACTURED TENOFOVIR (VIREAD) USED ALONG WITH LAMIVUDINE AND EFAVIRENZ TO TREAT THAI HIV PATIENTS.
    Manosuthi W; Thongyen S; Nilkamhang S; Manosuthi S; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2015 Jan; 46(1):19-26. PubMed ID: 26513901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study.
    de Jong MA; Wisaksana R; Meijerink H; Indrati A; van de Ven AJ; Alisjahbana B; van Crevel R
    Trop Med Int Health; 2012 May; 17(5):581-3. PubMed ID: 22364582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.
    Olsen CH; Gatell J; Ledergerber B; Katlama C; Friis-Møller N; Weber J; Horban A; Staszewski S; Lundgren JD; Phillips AN;
    AIDS; 2005 Feb; 19(3):319-30. PubMed ID: 15718843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of HIV-1-related disease among outpatients in New York City.
    Greenberg AE; Thomas PA; Landesman SH; Mildvan D; Seidlin M; Friedland GH; Holzman R; Starrett B; Braun J; Bryan EL
    AIDS; 1992 Aug; 6(8):849-59. PubMed ID: 1418782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].
    ;
    Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):32-53. PubMed ID: 17261244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4 counts in laboratory monitoring of HIV disease--experience from western India.
    Ingole N; Nataraj G; Mehta P; Paranjpe S; Sarkate P
    J Int Assoc Provid AIDS Care; 2014; 13(4):324-7. PubMed ID: 25513028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of HIV disease burden by calculating the percentages of patients with CD4 counts <100 cells/µL across 52 districts reveals hot spots for intensified commitment to programmatic support.
    Coetzee LM; Cassim N; Glencross DK
    S Afr Med J; 2017 May; 107(6):507-513. PubMed ID: 28604323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapy.
    Lodwick RK; Nakagawa F; van Sighem A; Sabin CA; Phillips AN
    PLoS One; 2015; 10(3):e0121992. PubMed ID: 25768925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
    Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
    AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).
    Solomon L; Stein M; Flynn C; Schuman P; Schoenbaum E; Moore J; Holmberg S; Graham NM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):253-61. PubMed ID: 9495226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low Body Mass Index as a Risk Factor for Antiretroviral Drug-Related Liver Injury Among HIV Patients.
    Budiman B; Hartantri Y; Susandi E; Agustanti N
    Acta Med Indones; 2019 Jul; 51(3):214-219. PubMed ID: 31699944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation.
    MMWR Recomm Rep; 1998 Apr; 47(RR-5):43-82. PubMed ID: 9572121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
    J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral drugs in the treatment of people living with human immunodeficiency virus: experience in a south Indian tertiary referral centre.
    Kumarasamy N; Solomon S; Peters E; Amalraj RE; Purnima M; Ravikumar B; Yepthomi T; Thyagarajan SP
    J Assoc Physicians India; 2000 Apr; 48(4):390-3. PubMed ID: 11273171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
    MacArthur RD; Novak RM; Peng G; Chen L; Xiang Y; Hullsiek KH; Kozal MJ; van den Berg-Wolf M; Henely C; Schmetter B; Dehlinger M; ;
    Lancet; 2006 Dec; 368(9553):2125-35. PubMed ID: 17174704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.